Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,931 | -10,604 | -42,942 | -32,044 | -21,195 |
| Depreciation Amortization | 584 | 285 | 709 | 435 | 262 |
| Accounts payable and accrued liabilities | -3,730 | -982 | 5,764 | 4,147 | 3,196 |
| Other Working Capital | -4,141 | -1,249 | -199 | -600 | -1,987 |
| Other Operating Activity | 7,423 | 2,612 | 3,033 | 2,883 | 1,721 |
| Operating Cash Flow | $-18,796 | $-9,938 | $-33,636 | $-25,179 | $-18,003 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-29 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -27 | -14 | -59 | -46 | -33 |
| Common Stock Issued | 20,026 | 20,026 | 16,436 | 5,656 | 4,841 |
| Financing Cash Flow | $19,998 | $20,012 | $16,377 | $5,610 | $4,808 |
| Beginning Cash Position | 56,561 | 56,561 | 73,820 | 73,820 | 73,820 |
| End Cash Position | 57,734 | 66,634 | 56,561 | 54,251 | 60,625 |
| Net Cash Flow | $1,173 | $10,074 | $-17,260 | $-19,569 | $-13,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,796 | -9,938 | -33,636 | -25,179 | -18,003 |
| Capital Expenditure | -29 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -18,825 | -9,938 | -33,636 | -25,179 | -18,003 |